EN
登录

Kazia Therapeutics (KZIA)股票因乳腺癌药物的积极临床前数据飙升77%

Kazia Therapeutics (KZIA) Stock Surges 77% On Positive Preclinical Data For Breast Cancer Drug

benzinga 等信源发布 2025-06-11 13:07

可切换为仅中文


Shares of

股票

Kazia Therapeutics Ltd

卡齐亚治疗有限公司

KZIA

KZIA

are surging Wednesday following the announcement of preclinical research findings for its lead drug candidate, paxalisib.

周三,其主要候选药物paxalisib的临床前研究结果公布后,股价飙升。

What To Know:

需要知道的内容:

The clinical-stage biotechnology

临床阶段的生物技术

revealed

揭示

data published in the peer-reviewed journal

发表在同行评审期刊上的数据

Molecular Cancer Therapeutics

分子癌症治疗学

highlighting paxalisib’s potential in treating triple-negative breast cancer.

突出显示了paxalisib在治疗三阴性乳腺癌方面的潜力。

The research, conducted at the QIMR Berghofer Medical Research Institute, demonstrated that paxalisib could reprogram the tumor microenvironment to enhance immune response. The study found that combining paxalisib with an immune checkpoint inhibitor resulted in synergistic antitumor activity and prolonged survival in preclinical models..

这项在QIMR Berghofer医学研究所进行的研究表明,paxalisib能够重新编程肿瘤微环境以增强免疫反应。研究发现,在临床前模型中,将paxalisib与免疫检查点抑制剂联合使用可产生协同抗肿瘤活性,并延长生存期。

Read Also:

另请阅读:

Talen Energy Stock Surges On Expanded Nuclear Power Deal With Amazon

塔伦能源公司因与亚马逊扩大核电协议,股票大涨。

“This landmark study offers a mechanistic and translational foundation for our newly launched Phase 1b clinical trial of paxalisib in advanced breast cancer,” stated Kazia’s CEO,

“这项具有里程碑意义的研究为我们在晚期乳腺癌中开展的Paxalisib 1b期临床试验提供了机制和转化基础,”Kazia首席执行官表示。

Dr. John Friend

约翰·弗兰德博士

. He

。他

noted

已备注

that the findings position the drug at the forefront of innovative immunotherapy combinations. The company recently dosed the first patient in this trial.

这些发现使该药物处于创新免疫疗法组合的前沿。该公司最近在这个试验中给第一位患者服用了药物。

What To Know:

需要了解的内容:

According to data from

根据数据来自

Benzinga Pro

Benzinga Pro

, the positive news sent Kazia shares soaring. The stock was trading up over 79.6% at $9.44 in late morning trading. Volume is exceptionally high, with over 41 million shares exchanged Wednesday morning compared to its 100-day average of just over 31,000 shares.

,这一利好消息使Kazia的股价飙升。该股在上午晚些时候的交易中上涨超过79.6%,达到9.44美元。交易量异常高,周三上午换手的股票超过4100万股,而其100天平均交易量仅为31000股。

Read Also:

另请阅读:

What’s Going On With GameStop Stock Wednesday?

周三GameStop股票发生了什么?

How To Buy KZIA Stock

如何购买KZIA股票

By now you're likely curious about how to participate in the market for Kazia Therapeutics – be it to purchase shares, or even attempt to bet against the company.

到目前为止,你可能已经对如何参与Kazia Therapeutics的市场感兴趣了——无论是购买股票,甚至是尝试押注这家公司。

Buying shares is typically done through a brokerage account. You can find a list of

购买股票通常通过经纪账户进行。您可以找到一个列表

possible trading platforms here.

这里有可能的交易平台。

Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.

许多平台会允许你购买“零碎股”,这使得你无需购买一整股就可以拥有部分股票。

In the case of Kazia Therapeutics, which is trading at $9.44 as of publishing time, $100 would buy you 10.6 shares of stock.

在Kazia Therapeutics的案例中,截至发布时其股价为9.44美元,100美元可以购买10.6股股票。

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a

如果你想押注一家公司股价下跌,这个过程会更复杂。你需要有一个期权交易平台,或者一个经纪人允许你通过借入股票来“做空”一股股票进行卖出。做空的的过程

stock can be found at this resource.

库存可以在这个资源中找到。

Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

否则,如果您的经纪人允许您交易期权,您可以买入看跌期权,或者在高于当前股价的行权价卖出看涨期权——无论哪种方式,都可以让您从股价下跌中获利。

According to data from Benzinga Pro, KZIA has a 52-week high of $79.00 and a 52-week low of $2.86.

根据Benzinga Pro的数据,KZIA的52周最高价为79.00美元,52周最低价为2.86美元。

Image: Shutterstock

图片:Shutterstock

Loading...

加载中...

Loading...

加载中...

KZIA

克齐亚

Kazia Therapeutics Ltd

卡齐亚治疗有限公司

$9.49

9.49美元

80.6

80.6

%

%

Stock Score Locked: Edge Members Only

股票评分锁定:仅限Edge会员

Benzinga Rankings give you vital metrics on any stock – anytime.

Benzinga排名为您提供任何股票的关键指标——随时。

Unlock Rankings

解锁排名

Edge Rankings

边缘排名

Momentum

动量

4.45

4.45

Growth

成长

Not Available

不可用

Quality

质量

Not Available

不可用

Value

28.88

28.88

Price Trend

价格趋势

Short

短的

Medium

中等

Long

Overview

概述

Market News and Data brought to you by Benzinga APIs

由Benzinga API提供的市场新闻和数据

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

© 2025 Benzinga.com. Benzinga 不提供投资建议。保留所有权利。